期刊文献+

糖尿病对维持性血透患者长期生存率的影响 被引量:2

The impact of diabetic on long-term survival in uremic patients during maintenance hemodialysis
原文传递
导出
摘要 目的 探讨合并糖尿病对维持性血液透析患者的长期生存率及并发症的影响.方法 选取维持性血液透析患者70例,根据是否合并糖尿病分为2组,统计1年及3年死亡率,观察患者血透过程中有无低血糖.病程中心血管并发症、严重感染和脑血管意外发生率,监测生化指标.结果 合并糖尿病的患者3年死亡率较高(p<0.05),心血管并发症,低血糖和感染发生率较高(P<0.05),贫血、低蛋白血症及高脂血症较明显(P<0.05).结论 合并糖尿病的维持性血透患者长期生存率较低,并发症发生率较高.
机构地区 [
出处 《中国临床实用医学》 2007年第4期-,共3页 China Clinical Practical Medicine
  • 相关文献

参考文献10

  • 1孙喜明,李兴.HGF对糖尿病及心血管并发症的治疗作用[J].医学综述,2006,12(1):39-41. 被引量:9
  • 2Nakagami H,Morishita R,Yamamoto K,etal. Hepatocyte growth factor prevents endothelial cell death through inhibition of bax translocation feom cytosol to mitochondfial membrane[J].Diabetes,2002,(08):2604-2611.doi:10.2337/diabetes.51.8.2604.
  • 3高妍.餐后高血糖与心血管合并症[J].国外医学(内分泌学分册),2002,22(3):145-148. 被引量:24
  • 4陈灏珠.实用内科学.上海医科大学《实用内科学》编委会第10版,下册[M].,.1440.
  • 5南国珍,周红,张力辉,王淑云,孙宝佳.糖尿病并发感染891例临床分析[J].河北医科大学学报,2000,21(2):70-71. 被引量:11
  • 6白晶,田亚平,郭广宏,董宁,韩国平.老年Ⅱ型糖尿病患者免疫状况的研究[J].感染.炎症.修复,2006(3):135-138. 被引量:3
  • 7刘东,伦立德,刘杰,田伟,张赤兵.血液透析对血糖的影响[J].空军总医院学报,2006,22(2):66-67. 被引量:13
  • 8Jackson MA,Holland MR,Nicholas J. Occult hypoglycemia caused by hemodialysis[J].Clinical Nephrology,1999,(14):242-247.
  • 9Jackson MA,Holland MR,Nicholas J. Hemodialysis induced hypoglycemia in diabetic patients[J].Clinical Nephrology,2000,(01):30-34.
  • 10Biesenbach G,Debska Slizien A,Zazgomik J. Nutritional status in type 2 diabetic patients requiring hemodialysis[J].Nephrology Dialysis Transplantation,1999,(03):655.doi:10.1093/ndt/14.3.655.

二级参考文献27

  • 1林其燧,陈立奇,吴卫,宋耀虹.外周淋巴细胞脱氧核糖核酸核蛋白体转录活性分析[J].中华医学检验杂志,1996,19(4):220-222. 被引量:87
  • 2高立民 亓文波.糖尿病并发感染162例临床分析[J].中华内分泌代谢杂志,1988,4(3):178-178.
  • 3朱昀 韩静萱.急性心肌梗塞病人肝细胞生长因子的产生[J].中国循环杂志,2000,101:10-12.
  • 4Jackson MA,Holland MR,Nicholas J,et al.Occult hypoglycemia caused by hemodialysis[J].Clin Nephrol,1999,51(4):242-247.
  • 5Jackson MA,Holland MR,Nicholas J,et al.Hemodialysis-induced hypoglycemia in diabetic patients[J].Clin Nephrol,2000,54(1):30-34.
  • 6Catalano C,Bordin V,Fabbian F,et al.Glucose-free standard hemodialysis and occult hypoglycemia[J].Clin Nephrology,2000,53(3):235-236.
  • 7Murakami N, Koufuji K, Shirouzu K. Influence of hepatocyte growth factor secreted from fibroblasts on the growth and invasion of seirrhous gastric cancer[J] ,Int Surg,2001,86(3) : 151-157.
  • 8Reddy V, Huh CG, Thorgeirsson S, et al. Intact Signaliag Via the Hepatocyte Growth Factor(HGF) Receptor, c-Met, Is Required for Normal Glucose Tolerance and Beta Cell Function : Conditioaal Kaockout of c-Met in the Beta Cell[J]. Diabetes,2003,52[Suppl 1] :A384.
  • 9Zhang YC, Atkinson MA. Gene therapy for type 1 diabetes: metabolism,immunity, islet cell preservation, and regeneration [ J ]. Curt Opin Endocrinol Diabetes, 2004,11 (2) : 91-97.
  • 10Lopoz-Talavera JC, Garcia-Oeana A, Sipula I, et al. Hepatocyte growth factor gene therapy for pancreatic islets in diabetes: reducing the minimal islet transplant mass required in a glucocortlcoid-free rat model of allogeneic portal vein islet transplantation[J]. Endocrinology, 2004,145.

共引文献69

同被引文献16

引证文献2

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部